The lollypop test uses saliva specimen. The test card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in saliva specimens directly collected from individuals who are suspected of COVID-19 within the first 7 days of symptom onset.
The lollypop test uses a double-antibody sandwich method to detect the antigen of novel coronavirus (SARS-CoV-2) in saliva samples. During detection, the gold-labeled anti-N-protein monoclonal antibody in the labeling pad binds to the viral N-antigen of SARS-CoV-2 in the sample to form a complex, and the reaction complex moves forward along the nitrocellulose membrane under the action of chromatography, it is captured by the anti-N-protein monoclonal antibody pre-coated by the detection zone (T) on the nitrocellulose membrane, and finally a red color reaction line is formed in the T zone. If the sample does not contain the viral N-antigen, a red color reaction line cannot be formed in the T zone. Regardless of whether the sample to be tested contains the N-antigen, a red reaction line will always form in the quality control area (C).
Below is an instructional video that explains how this rapid test is administered.
After completion, Goffin Molecular Technologies will contact you as soon as possible.